Welcome to LookChem.com Sign In|Join Free
  • or
N-(dimethylphosphinyl)-N-benzyl-D-leucine methyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

204275-01-4

Post Buying Request

204275-01-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

204275-01-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 204275-01-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,4,2,7 and 5 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 204275-01:
(8*2)+(7*0)+(6*4)+(5*2)+(4*7)+(3*5)+(2*0)+(1*1)=94
94 % 10 = 4
So 204275-01-4 is a valid CAS Registry Number.

204275-01-4Downstream Products

204275-01-4Relevant academic research and scientific papers

PHOSPHINIC ACID AMIDES AS MATRIX METALLOPROTEASE INHIBITORS

-

, (2008/06/13)

The invention provides compounds which are useful as inhibitors of matrix metalloproteases, and which are effective in treating conditions characterized by excess activity of these enzymes. In particular, the present invention relates to a compound having

Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases

Pikul, Stanislaw,McDow Dunham, Kelly L.,Almstead, Neil G.,De, Biswanath,Natchus, Michael G.,Anastasio, Melanie V.,McPhail, Sara J.,Snider, Catherine E.,Taiwo, Yetunde O.,Chen, Longyin,Dunaway, C. Michelle,Gu, Fei,Mieling, Glen E.

, p. 87 - 94 (2007/10/03)

A new series of hydroxamic acid-based matrix metalloproteinase (MMP) inhibitors containing a unique phosphinamide motif derived from D-amino acid was designed, synthesized, and tested for enzyme inhibition. Compounds with an R configuration at phosphorus

PHOSPHINIC ACID AMIDES AS MATRIX METALLOPROTEASE INHIBITORS

-

, (2008/06/13)

The invention provides compounds which are useful as inhibitors of matrix metalloproteases, and which are effective in treating conditions characterized by excess activity of these enzymes. In particular, the present invention relates to a compound having

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 204275-01-4